Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0Nutrients

Ginsenoside Compound K Inhibits Pancreatic Cancer by Induction of Canonical Pyroptosis Associated with HAPLN1 Signaling

  1. 1Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, Biotech & Biomed Research Institute, School of Chemical Engineering, Northwest University, Xi’an 710127, China
  2. 2College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China
  3. 3State Key Laboratory of Vegetable Biobreeding, Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, Beijing 100081, China

Abstract

Background: Pancreatic cancer (PC) remains one of the most lethal malignancies because of its highly immunosuppressive tumor microenvironment and profound resistance to current therapies. Increasing evidence suggests that pyroptosis, a pro-inflammatory form of programmed cell death, may provide a promising strategy for enhancing anti-tumor immunity and improving therapeutic responsiveness. Ginsenoside Compound K (CK), a major bioactive intestinal metabolite of Panax ginseng, exhibits diverse pharmacological and anti-tumor activities. However, whether its anti-PC effects involve the induction of tumor cell pyroptosis remains unclear. Methods: The anti-tumor effects and underlying mechanisms of CK were investigated in Panc02 tumor-bearing mice and BxPC-3 pancreatic cancer cells. Tumor growth, systemic toxicity, pyroptosis-related events, reactive oxygen species (ROS) production and the involvement of the HAPLN1–TNFα/NF-κB signaling pathway were evaluated. Pharmacological inhibition of ROS and caspase-1 was employed to verify the mechanism of CK-induced pyroptosis. Results: CK significantly suppressed tumor growth without causing apparent systemic toxicity and induced characteristic pyroptotic changes, including caspase-1 activation, enhanced lactate dehydrogenase release, and disruption of mitochondrial membrane potential. Mechanistically, CK promoted intracellular ROS accumulation and activated the HAPLN1–TNFα/NF-κB axis, leading to NLRP3 inflammasome activation and subsequent cleavage of caspase-1 and gasdermin D (GSDMD). And either ROS scavenging or caspase-1 inhibition markedly attenuated CK-induced pyroptosis. Conclusions: CK exerts potent anti-pancreatic cancer activity by promoting ROS/NLRP3-dependent pyroptosis and is associated with HAPLN1-related inflammatory signaling, supporting its further development as a therapeutic candidate for pancreatic cancer.

Related

  1. Ginsenoside Re attenuates severe acute pancreatitis-associated acute lung injury by inhibiting pancreatic necroptosis-driven cfDNA release and pulmonary cGAS-STING activation
    Cheng Hu, Rui Yang, Wenjuan Luo +7
    Journal of Ginseng ResearchPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaDOAJEurope PMCPMC
  2. Venetoclax Resistance Creates Canonical Pyroptosis Vulnerability in AML
    Q. Wang, S. Xu, J. Cai +16
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Synergistic induction of pyroptosis-like cell death in colorectal cancer cells by norcantharidin and low-dose oxaliplatin promotes M1 macrophage polarization
    Jia Lang, XueLian Zhu, Qian Chen +3
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  4. ER stress-associated apoptosis and pyroptosis-like changes in Kikuchi–Fujimoto disease
    Shigeyuki Asano, Koji Shikano, Kazuki Yamazaki +5
    Journal of Clinical and Experimental Hematopathology : JCEHPeer-reviewedCC BY-NC-SA 4.0Full textGeneral medicinePMC
  5. Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis
    Nicolas Benichou, Pierre Charles, Benjamin Terrier +9
    Kidney InternationalPeer-reviewedLicence not statedFull text57 citedImmunologyGeneral medicineHAL
BibTeX
@article{liu2026ginsenoside,
  title = {{Ginsenoside Compound K Inhibits Pancreatic Cancer by Induction of Canonical Pyroptosis Associated with HAPLN1 Signaling}},
  author = {Jingke Liu and Chao Fang and Haixia Yang and Daidi Fan and Jianjun Deng},
  journal = {Nutrients},
  year = {2026},
  month = nov,
  doi = {10.3390/nu18223757},
  url = {https://www.mdpi.com/2072-6643/18/22/3757},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Ginsenoside Compound K Inhibits Pancreatic Cancer by Induction of Canonical Pyroptosis Associated with HAPLN1 Signaling
AU  - Jingke Liu
AU  - Chao Fang
AU  - Haixia Yang
AU  - Daidi Fan
AU  - Jianjun Deng
PY  - 2026
DA  - 2026/11/12
JO  - Nutrients
DO  - 10.3390/nu18223757
UR  - https://www.mdpi.com/2072-6643/18/22/3757
AB  - Background: Pancreatic cancer (PC) remains one of the most lethal malignancies because of its highly immunosuppressive tumor microenvironment and profound resistance to current therapies. Increasing evidence suggests that pyroptosis, a pro-inflammatory form of programmed cell death, may provide a promising strategy for enhancing anti-tumor immunity and improving therapeutic responsiveness. Ginsenoside Compound K (CK), a major bioactive intestinal metabolite of Panax ginseng, exhibits diverse pharmacological and anti-tumor activities. However, whether its anti-PC effects involve the induction of tumor cell pyroptosis remains unclear. Methods: The anti-tumor effects and underlying mechanisms of CK were investigated in Panc02 tumor-bearing mice and BxPC-3 pancreatic cancer cells. Tumor growth, systemic toxicity, pyroptosis-related events, reactive oxygen species (ROS) production and the involvement of the HAPLN1–TNFα/NF-κB signaling pathway were evaluated. Pharmacological inhibition of ROS and caspase-1 was employed to verify the mechanism of CK-induced pyroptosis. Results: CK significantly suppressed tumor growth without causing apparent systemic toxicity and induced characteristic pyroptotic changes, including caspase-1 activation, enhanced lactate dehydrogenase release, and disruption of mitochondrial membrane potential. Mechanistically, CK promoted intracellular ROS accumulation and activated the HAPLN1–TNFα/NF-κB axis, leading to NLRP3 inflammasome activation and subsequent cleavage of caspase-1 and gasdermin D (GSDMD). And either ROS scavenging or caspase-1 inhibition markedly attenuated CK-induced pyroptosis. Conclusions: CK exerts potent anti-pancreatic cancer activity by promoting ROS/NLRP3-dependent pyroptosis and is associated with HAPLN1-related inflammatory signaling, supporting its further development as a therapeutic candidate for pancreatic cancer.
SN  - 2072-6643
ER  -